LIQID - Model OptiShunt V2 - Flagship Device

The OptiShuntV2 is the follow-on device which incorporates design optimisation changes and is set for clinical trials kicking off in January 2022. The device includes a two-part construction and an upgraded shunt insertion system to make the device simpler, safer, and even more effective.